ITEM 1.01 - ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On December 31, 2018, CleanSpark, Inc. (the “Company”)
entered into a Securities Purchase Agreement (the “SPA”) with an otherwise unaffiliated third-party institutional investor
(the “Investor”), pursuant to which the Company issued to the Investor a Senior Secured Redeemable Convertible Debenture
(the “Debenture”) in the aggregate face value of $5,250,000. The Debenture has a maturity date two years from the issuance
date and the Company has agreed to pay compounded interest on the unpaid principal balance of the Debenture at the rate equal 7.5%
per annum. Interest is payable on the date the applicable principal is converted or on maturity. The interest must be paid in cash
and, in certain circumstances, may be paid in shares of common stock.
The transactions described above closed on December 31, 2018. In
connection with the issuance of the Debenture and pursuant to the terms of the SPA, the Company issued to the Investor a Common
Stock Purchase Warrant to acquire up to 3,083,333 shares of common stock for a term of three years (the “Warrant”)
on a cash-only basis at an exercise price of $2.00 per share with respect to 1,250,000 Warrant Shares, $2.50 with respect to 1,000,000
Warrant Shares, $5.00 with respect to 500,000 Warrant Shares and $7.50 with respect to 333,333 Warrant Shares
Pursuant to the terms of the SPA, the Investor agreed to tender
to the Company the sum of $5,000,000, of which the Company received the full amount as of the closing. As of the closing, the number
of warrant shares was 3,083,333.
Pursuant to the Securities Purchase Agreement, the Company agreed
to sell the Debenture, the shares of common stock issuable upon conversion of the Debenture, the Warrant and the shares of common
stock issuable upon exercise of the Warrant pursuant to an effective shelf registration statement on Form S-3 (Registration No
333-228063), declared effective by the Securities and Exchange Commission on November 20, 2018, and a related prospectus supplement
thereto.
Prior to the maturity date, provided that no trigger event has occurred,
the Company will have the right at any time upon 30 trading days’ prior written notice, in its sole and absolute discretion,
to redeem all or any portion of the Debenture then outstanding by paying to the Investor an amount equal to 140% of the of the
portion of the Debenture being redeemed.
The Investor may convert the Debenture into shares of the Company’s
common stock at a conversion price equal to 95% of the mathematical average of the 5 lowest individual daily volume weighted average
prices of the common stock, less $.05 per share, during the period beginning on the issuance date and ending on the maturity date.
There is a floor price of $0.12 per share. In the event certain equity conditions exist, the Company may require that the Investor
convert the Debenture. In no event shall the Debenture be allowed to effect a conversion if such conversion, along with all other
shares of Company common stock beneficially owned by the Investor and its affiliates would exceed 4.9% of the outstanding shares
of the common stock of the Company.
The foregoing description of the terms of the above transactions
do not purport to be complete and are qualified in their entirety by reference to the provisions of such agreements, the forms
of which are filed as exhibits to this Current Report on Form 8-K.